K Number
K980777
Device Name
DUMEX PAK-ITS-ABSORBASALT COTTON GAUZE PACKING
Date Cleared
1998-05-04

(63 days)

Product Code
Regulation Number
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The "AbsorbaSalt" Cotton Gauze Packing is a dry dressing impregnated with crystalline seawater salt that is intended for use on moderately to heavily exudating wounds. The dressing will Sur that is mondou for act on moist hypertonic environment when applied to a wound. A moist wound environment will support autolytic debridement of the dressing is appropriate would offications will our cuts, minor burns and minor lacerations. Under the guidance for the following multions: himor outs, rather attern Gauze Packing is also indicated for surgical incisions and excisions, venous stasis ulcers, pressure ulcers and decubitus ulcers.
Device Description
The "AbsorbaSalt" Cotton Gauze Packing is a dry dressing impregnated with crystalline seawater salt.
More Information

Not Found

Not Found

No
The summary describes a simple wound dressing and contains no mention of AI, ML, or related concepts like image processing or performance metrics typically associated with AI/ML devices.

No
The device is a dressing used to support wound healing, which is a supportive rather than a therapeutic function.

No

This device is a wound dressing designed to create a moist healing environment and support debridement; it does not diagnose a condition.

No

The device description clearly states it is a "dry dressing impregnated with crystalline seawater salt," which is a physical medical device, not software.

Based on the provided information, the "AbsorbaSalt" Cotton Gauze Packing is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices intended for use in vitro for the examination of specimens, including blood, tissue, and urine, derived from the human body, solely or principally for the purpose of providing information concerning a physiological or pathological state, or a congenital abnormality, or to determine the safety and compatibility with potential recipients, or to monitor therapeutic measures.
  • AbsorbaSalt Function: The description clearly states that the AbsorbaSalt is a dressing applied directly to wounds on the body. Its function is to create a moist hypertonic environment to support wound healing processes like autolytic debridement.
  • No Specimen Examination: There is no mention of the device being used to examine specimens derived from the human body in a laboratory setting.

Therefore, the AbsorbaSalt Cotton Gauze Packing is a topical wound dressing, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The "AbsorbaSalt" Cotton Gauze Packing is a dry dressing impregnated with crystalline seawater salt that is intended for use on moderately to heavily exudating wounds. The dressing will Sur that is mondou for act on moist hypertonic environment when applied to a wound. A moist wound environment will support autolytic debridement of the dressing is appropriate would offications will our cuts, minor burns and minor lacerations. Under the guidance for the following multions: himor outs, rather attern Gauze Packing is also indicated for surgical incisions and excisions, venous stasis ulcers, pressure ulcers and decubitus ulcers.

Product codes

MGP

Device Description

Dumex Pak-its "AbsorbaSalt" Cotton Gauze Packing

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Not Found

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

N/A

0

Image /page/0/Picture/1 description: The image is a seal for the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an emblem that features a stylized caduceus, a symbol often associated with medicine and healthcare. The caduceus is depicted with a staff entwined by two snakes and topped with wings.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAY 4 1998

Mr. Sharmini Atheray, M.Sc Manager for QA/RA Dumex Medical Surgical Products Limited 104 Shorting Road Scarborough, Ontario, Canada M1S3S4

Re: K980777

Trade Name: Dumex Pak-its "AbsorbaSalt" Cotton Gauze Packing Regulatory Class: Unclassified Product Code: MGP Dated: February 27, 1998 Received: March 2, 1998

Dear Mr. Atheray:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act). You may, therefore, market your device subject to the general controls provisions of the Federal Food, Drug, and Cosmetic Act (Act) and the following limitations:

    1. This device may not be labeled for use on third degree burns.
    1. This device may not be labeled as having any accelerating effect on the rate of wound healing or epithelization.
    1. This device may not be labeled as a long-term, permanent, or no-change dressing, or as an artificial (synthetic) skin: -------------------------------------------------------------------------------------------------------------------------------------------
    1. This device may not be labeled as a treatment or a cure for any type of wound.

The labeling claims listed above would be considered a major modification in the intended use of the device and would require a premarket notification submission (21 CFR 807.81).

The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practices, labeling, and prohibitions against misbranding and adulteration.

1

Page 2 - Mr. Atheray

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations (CFR), Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practices (GMP) for Medical Devices: General GMP regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or 301-443-6597 or at its internet address http://www.fda.gov/cdrh/dsmamain.html.

Sincerely yours,

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

  • National Andre

Enclosure

2

9

Form B

Indications for Use Form

510(k) Number (if known):

Device Name: Dumex Pak - ils - Absosberga

Indications for Use:

12:36

The "AbsorbaSalt" Cotton Gauze Packing is a dry dressing impregnated with crystalline seawater salt that is intended for use on moderately to heavily exudating wounds. The dressing will Sur that is mondou for act on moist hypertonic environment when applied to a wound. A moist wound environment will support autolytic debridement of the dressing is appropriate would offications will our cuts, minor burns and minor lacerations. Under the guidance for the following multions: himor outs, rather attern Gauze Packing is also indicated for surgical incisions and excisions, venous stasis ulcers, pressure ulcers and decubitus ulcers.

PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Or

Over-the-Counter Use

boee

(Division Sign-Off)
Division of General Restorative Devices
510(k) Number. K980777